Vimarsana
Biggest News Aggregation in the World

Cellular Therapy Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cellular Therapy Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cellular Therapy Program Today - Breaking & Trending Today

Natalie Dickson, MD, MMHC, FASCO, FACP, of Tennessee Oncology Discusses Cutting-Edge Cancer Care Initiatives - Vimarsana News

Natalie Dickson, MD, MMHC, FASCO, FACP, of Tennessee Oncology Discusses Cutting-Edge Cancer Care Initiatives

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Source: ajmc.com
Dr Pantin on the Evolving Treatment Paradigm in PNH - Vimarsana News

Dr Pantin on the Evolving Treatment Paradigm in PNH

Jeremy M. Pantin, MD, discusses the evolution of the PNH treatment paradigm and agents that are available or being investigated in this disease.

UK breaks ground on new Cancer and Advanced Ambulatory Building - Vimarsana News

UK breaks ground on new Cancer and Advanced Ambulatory Building

The University of Kentucky broke ground today on the new UK Cancer and Advanced Ambulatory Building, located across from UK Albert B. Chandler Hospital on South Limestone. The 550,000-square-foot facility will become the new home to the UK Markey Cancer Center, Kentucky's only National Cancer Institute-designated Comprehensive Cancer Center, as well as a Comprehensive Spine Center, ambulatory surgery space, and other outpatient services.  The Cancer and Advanced Ambulatory Building and an adjacent 2,400-space parking structure are slated for completion in 2027.   

Source: uky.edu
Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy - Vimarsana News

Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy

20.02.2024 - Omeros Corporation (Nasdaq: OMER) today announced the upcoming presentation of a report detailing narsoplimab treatment in nine adult patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). Narsoplimab is ... Seite 1

Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy - Vimarsana News

Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy

Omeros Corporation today announced the upcoming presentation of a report detailing narsoplimab treatment in nine adult patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). Narsoplimab is Omeros'...